A detailed history of Bank Of America Corp transactions in Nanobiotix S.A. stock. As of the latest transaction made, Bank Of America Corp holds 706 shares of NBTX stock, worth $2,485. This represents 0.0% of its overall portfolio holdings.

Number of Shares
706
Previous 760 7.11%
Holding current value
$2,485
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.68 - $6.0 $252 - $324
-54 Reduced 7.11%
706 $4,000
Q2 2024

Aug 14, 2024

BUY
$4.16 - $7.31 $2,071 - $3,640
498 Added 190.08%
760 $3,000
Q1 2024

May 15, 2024

BUY
$6.12 - $8.13 $740 - $983
121 Added 85.82%
262 $1,000
Q4 2023

Feb 14, 2024

BUY
$5.34 - $9.19 $752 - $1,295
141 New
141 $1,000

Others Institutions Holding NBTX

About Nanobiotix S.A.


  • Ticker NBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,875,900
  • Market Cap $123M
  • Description
  • Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...
More about NBTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.